2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure

Size: px
Start display at page:

Download "2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure"

Transcription

1 2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure Mike McCune, MD, PhD University of California, San Francisco

2 Cure Interventions that Can Be Used Around the World The Goal To discover, develop, test, and distribute cure interventions that are: Safe Effective Stable Scalable Affordable

3 Hurdles to cross

4 Hurdles to cross Science Which mechanisms enable HIV persistence? Which can be interrupted?

5 Hurdles to cross Science Which mechanisms enable HIV persistence? Which can be interrupted? People How can we create and incentivize collaborative, multidisciplinary teams to test hypotheses?

6 Hurdles to cross Science Which mechanisms enable HIV persistence? Which can be interrupted? People How can we create and incentivize collaborative, multidisciplinary teams to test hypotheses? Process With what infrastructure, which cohorts, and which bioassay will potential cures be prioritized?

7 Hurdles to cross Science Which mechanisms enable HIV persistence? Which can be interrupted? People How can we create and incentivize collaborative, multidisciplinary teams to test hypotheses? Process With what infrastructure, which cohorts, and which bioassay will potential cures be prioritized? Distribution If have a cure in hand, how can we assure its world-wide distribution?

8 The Process of Bringing Better Therapies to the World Bench Clinic Community

9 The Early Stages of this Process Are Done Well by Academic Centers Solo scientists Single discipline Bench Discovery driven Clinic Innovative Academic Center

10 The Later Stages Are Better Performed by Biotech/Pharma Clinic Multidisciplinary teams Practical solutions Profit oriented Community Biotech/Pharma

11 A New Model Is Needed to Bring Cures to Resource-Poor Settings Bench Discovery driven Innovative Clinic Multidisciplinary teams Practical solutions Academic Center Community Biotech/Pharma

12 Public-Private Partnership Definition An informal or formal arrangement between one or more public sector entities and one or more private sector entities To achieve a public health objective or to produce a health-related product or service for the public good. To share certain risks and to exchange intellectual property, financial, in-kind, and/or human resources in any mutually agreed upon proportion.

13 Public-Private Partnership: Benefits Created to provide urgently needed therapies for neglected diseases: Malaria Tuberculosis Dengue Leishmaniasis African trypanosomiasis Chagas Enable effective merger of strengths in academia, industry, and non-governmental organizations

14 Public-Private Partnership: Ongoing Efforts National Institutes of Health Cure Collaboratories International AIDS Society Forum for Collaborative HIV Research American Foundation for AIDS Research

15 Public-Private Partnership: The Sunnylands Initiative HIV Cure Public-Private Partnership Initiative November 2013: The Annenberg Foundation Trust at Sunnylands convened an international group of leaders from science, government, philanthropy, and industry to address issues associated with HIV cure.

16 Public-Private Partnership: The Sunnylands Initiative HIV Cure Public-Private Partnership Initiative November 2013: The Annenberg Foundation Trust at Sunnylands convened an international group of leaders from science, government, philanthropy, and industry to address issues associated with HIV cure. Key question: How can these groups work together to most efficiently deliver safe, effective, and affordable cure interventions for use around the world?

17 Public-Private Partnership: The Sunnylands Initiative HIV Cure Public-Private Partnership Initiative Resolved To identify, test, and distribute interventions that will, in conjunction with effective antiretroviral therapy, lead to a drug-free remission (or cure ) in HIV-infected individuals. To work together to develop new pathways to amplify existing HIV cure efforts. To overcome barriers to success through greater collaboration.

18 Public-Private Partnership: The Sunnylands Initiative HIV Cure Public-Private Partnership Initiative Growing Status Designed to be inclusive Governance procedures being put into place Focused on three general topics

19 HIV Cure Public-Private Partnership Initiative: Creation of a Strategic Plan Development of a Roadmap: Highlighting priority areas of activity, identifying major barriers to developing, producing, and distributing an HIV cure, and setting forth major milestones associated with scientific, clinical, regulatory, production, and distribution/access efforts that will guide stakeholder efforts over the next 20 years.

20 HIV Cure Public-Private Partnership Initiative: Quantifying the Reservoir Discovery and standardization of a biomarker: Focused on the development and standardization of novel methods for quantifying HIV persistence that are: capable of quantifying the total body burden of SIV in relevant long-term treated nonhuman primates predictive of time to virologic rebound during carefullymonitored analytic treatment interruptions blood-based high throughput applicable for routine clinical settings

21 HIV Cure Public-Private Partnership Initiative: Making Cures Affordable Establishment of a business case: What are the financial and societal implications of achieving a cure for HIV disease that is accessible in both high and low resource settings? What are the incentives for entities within and across sectors to form collaborative bonds with one another to reach this goal?

22 Public-Private Partnership: The Sunnylands Initiative HIV Cure Public-Private Partnership Initiative For more information Ellen LaPointe, JD, is serving as the Project Director for the initiative and can be reached at

HEALTHCARE IN THE DEVELOPING WORLD - THE ROLE OF INTELLECTUAL PROPERTY. ODI: 12 February 2003

HEALTHCARE IN THE DEVELOPING WORLD - THE ROLE OF INTELLECTUAL PROPERTY. ODI: 12 February 2003 HEALTHCARE IN THE DEVELOPING WORLD - THE ROLE OF INTELLECTUAL PROPERTY ODI: 12 February 2003 KEY QUESTIONS What role does IP play in the development of new drugs and vaccines for the developing world?

More information

EC research and innovation strategy and actions

EC research and innovation strategy and actions EC research and innovation strategy and actions for preparedness and response to outbreaks IMI Stakeholder Forum 28-29 September 2016 Line Matthiessen Head of Unit E.3 Health Directorate DG Research &

More information

A Blueprint for Breast Cancer Deadline 2020

A Blueprint for Breast Cancer Deadline 2020 A Blueprint for Breast Cancer Deadline 2020 In 1991, the National Breast Cancer Coalition was formed with one mission: an end to breast cancer. NBCC has accomplished much over its twenty plus years: bringing

More information

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB RAPID DIAGNOSIS AND TREATMENT OF MDR-TB FORMING PARTNERSHIPS TO STRENGTHEN THE GLOBAL RESPONSE TO MDR-TB - WHERE IT MATTERS MOST I am delighted that this initiative will improve both the technology needed

More information

CPRIT Overview. Cancer Centers Administrators Forum April 4, 2016

CPRIT Overview. Cancer Centers Administrators Forum April 4, 2016 CPRIT Overview Cancer Centers Administrators Forum April 4, 2016 CPRIT s Unique Role in the Fight Against Cancer Overview: Created by the Texas Legislature and citizens in 2007 $3 billion over 10 years

More information

4. Project Inform does receive restricted donations from corporations, non-profits, foundations, and government entities.

4. Project Inform does receive restricted donations from corporations, non-profits, foundations, and government entities. DONATION GUIDELINES As a non-profit organization, Project Inform is able to fulfill its mission and provide services, free of charge, because of its fundraising and outreach efforts. Project Inform receives

More information

TRANS-NIH PLAN FOR HIV RELATED RESEARCH

TRANS-NIH PLAN FOR HIV RELATED RESEARCH National Institutes of Health FY 2018 TRANS-NIH PLAN FOR HIV RELATED RESEARCH Prepared by the Office of AIDS Research Maureen M. Goodenow, Ph.D. NIH Associate Director for AIDS Research and Director, Office

More information

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UNHLM ON TB KEY TARGETS FOR 2022 WE, HEADS OF STATE AND GOVERNMENT AND REPRESENTATIVES OF STATES AND GOVERNMENTS ASSEMBLED AT THE UNITED NATIONS

More information

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016 8 December 2016 39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland 6-8 December 2016 Decisions The UNAIDS Programme Coordinating Board, Recalling that all aspects of UNAIDS work

More information

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty Vision A community free of poverty Mission Hopelink s mission is to promote self-sufficiency for all members of our community; we help people make lasting change. Hopelink s Values Growth and Human Potential

More information

Global Action Against Dementia: Finding a Path Forward and the World Dementia Council

Global Action Against Dementia: Finding a Path Forward and the World Dementia Council Global Action Against Dementia: Finding a Path Forward and the World Dementia Council Raj Long MBPsS MSc Vice Chair World Dementia Council ASAD Hangzhou October 2016 1 Overview 1. Global State of Dementia

More information

Program Priorities 2018

Program Priorities 2018 Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term

More information

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,

More information

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan, 10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan, 2006 2015 Introduction A significant scaling-up of advocacy, communication and social mobilization for TB will

More information

Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards

Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Wendy K.D. Selig, President & CEO, MRA Julia Perkins, M.D. Medical Director, Oncology, Pfizer Melanoma Research Alliance Mission:

More information

Executive Summary 10

Executive Summary 10 Executive Summary 10 In this section 12 Introduction 13 Radiation Oncology Services in Australia Key Issues 15 2012-2022 Strategic Directions and Objectives for the Radiation Oncology Sector 17 Policy

More information

2018 Annual Summit June 12-14, 2018 Seattle Children s Hospital. CAC2.org

2018 Annual Summit June 12-14, 2018 Seattle Children s Hospital. CAC2.org 2018 Annual Summit June 12-14, 2018 Seattle Children s Hospital CAC2.org Our Purpose CAC2 is a collaborative network of organizations and individuals supporting and serving the childhood cancer community.

More information

Responding to Homelessness Needs Through Housing

Responding to Homelessness Needs Through Housing Responding to Homelessness Needs Through Housing Gail Thornhill, Director of Supportive Housing, Stella s Circle Executive Board Member, End Homelessness St. John s (NL) End Homelessness St. John s We

More information

The International Coalition to Eliminate Hepatitis B.

The International Coalition to Eliminate Hepatitis B. The International Coalition to Eliminate Hepatitis B. HBV is currently incurable However functional cure (HBsAg seroclearance) is observed in a small number of patients, either spontaneously or in the

More information

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Introduction The Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 provides an overarching policy framework

More information

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential

More information

REPORT. A Model Clinical Trials System for the 21st Century

REPORT. A Model Clinical Trials System for the 21st Century www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System

More information

Liver Forum Cirrhosis Working Group Arun J. Sanyal

Liver Forum Cirrhosis Working Group Arun J. Sanyal Liver Forum Cirrhosis Working Group Arun J. Sanyal Z Reno Vlahcevic Professor of Medicine VCU School of Medicine Richmond, VA 2 Liver Forum 8 DRUG DEVELOPMENT PATHWAYS Regular approval pathway: based on

More information

Emergency Plan. Pink Ribbon Red. under President. With. screened and Significantly. Commitments: to catalyze. a dynamic, including. of shared.

Emergency Plan. Pink Ribbon Red. under President. With. screened and Significantly. Commitments: to catalyze. a dynamic, including. of shared. Pink Ribbon Red Ribbon Overview Pink Ribbon Red Ribbon is an innovative partnership to leverage public and private investments in global health to combat cervical and breast cancer two of the leading causes

More information

Chronic hepatitis C Building access into drug development: DNDi strategy

Chronic hepatitis C Building access into drug development: DNDi strategy Chronic hepatitis C Building access into drug development: DNDi strategy July 2017 IAS Isabelle Andrieux-Meyer Head of HIV/HCV Clinical Programs Declaration of interests Isabelle Andrieux-Meyer from Drugs

More information

Translating Duke Health. Accelerating discovery and its translation

Translating Duke Health. Accelerating discovery and its translation Translating Duke Health Accelerating discovery and its translation Translating Duke Health Biomedical discovery is accelerating innovative and revolutionary advancements in our understanding of human biology,

More information

Driving access to medicine

Driving access to medicine Driving access to medicine An example from the Novartis Malaria Initiative Hans Rietveld Director, Market Access & Capacity Building Novartis Malaria Initiative Social Forum - Geneva February 20, 2015

More information

Parkinson s Research Program

Parkinson s Research Program Parkinson s Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military, and the public

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

GAVI, THE VACCINE ALLIANCE

GAVI, THE VACCINE ALLIANCE #vaccineswork GAVI, THE VACCINE ALLIANCE Partnerships for Health Outcomes Susan Brown July, 2017, New York Gavi/2012/Doune Porter www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and

More information

Treatments of tomorrow: dementia research and drug discovery. Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK

Treatments of tomorrow: dementia research and drug discovery. Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK Treatments of tomorrow: dementia research and drug discovery Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK More failure What is different about dementia drug discovery? The

More information

Women s Inclusion in HIV Clinical Research: Challenges and Successes

Women s Inclusion in HIV Clinical Research: Challenges and Successes Women s Inclusion in HIV Clinical Research: Challenges and Successes Mary Allegra Cermak ACTG Community Coordinator Sharon Maxwell Henkel Women s HIV Research Collaborative Co-Chair Annet Davis-Vogel Women

More information

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030 ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030 1. WE, the Heads of State and Government of the Association of Southeast

More information

Diabetes 360º. Q s and A s. Why is Diabetes Canada calling on the government to establish a national strategy for diabetes and why now?

Diabetes 360º. Q s and A s. Why is Diabetes Canada calling on the government to establish a national strategy for diabetes and why now? Diabetes 360º Q s and A s Why is Diabetes Canada calling on the government to establish a national strategy for diabetes and why now? We are experiencing an alarming trend of increased diabetes prevalence

More information

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

UNRAVELING THE MYSTERY BEHIND HIV/AIDS PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise

More information

Improving access to medicines for patients in lower-income countries

Improving access to medicines for patients in lower-income countries Improving access to medicines for patients in lower-income countries AHBS II Dakar November 6, 2017 Our access strategy: tailoring our approach to income segments Income segments 1 High Income Upper-middle

More information

The Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative

The Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative The Value of Product Development Partnerships in Vaccine Innovation Hansi J. Dean International AIDS Vaccine Initiative The Product Development Partnership Model A non-profit partnership of public and

More information

Health Department Role: Eliminating HBV and HCV

Health Department Role: Eliminating HBV and HCV Health Department Role: Eliminating HBV and HCV Mariah E. Johnson Senior Manager, Viral Hepatitis/Policy & Legislative Affairs 2015 USCA Hepatitis Pathway: Breaking the Silence: Eliminating Hepatitis B

More information

Surveillance and Prevention of NCDs : Applying LHS Principles to Kidney Disease

Surveillance and Prevention of NCDs : Applying LHS Principles to Kidney Disease Surveillance and Prevention of NCDs : Applying LHS Principles to Kidney Disease Rajiv Saran, MBBS, MD, MRCP, MS Florence E. Bingham Professor of Nephrology Professor of Medicine and Epidemiology Director,

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

Delaware Oral Health Plan 2014 Goals and Objectives VISION

Delaware Oral Health Plan 2014 Goals and Objectives VISION VISION All members of the Delaware population, regardless of age, ability, or financial status, will achieve optimal oral health through an integrated system which includes prevention, education and appropriate

More information

The Global AIESEC Leadership Initiative. Leadership for a Better World

The Global AIESEC Leadership Initiative. Leadership for a Better World The Global AIESEC Leadership Initiative 00 Leadership for a Better World 1 The Global AIESEC Leadership Initiative AIESEC youth and AIESEC alumni develop and activate leaders for a better world. Developing

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

Investments in Dairy Research : Building Partnerships for Innovation

Investments in Dairy Research : Building Partnerships for Innovation Investments in Dairy Research : Building Partnerships for Innovation Maria Kalergis, PhD, RD, CDE National Program Manager, Nutrition Scientific Affairs Dairy Farmers of Canada Dairy Farmers of Canada

More information

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan Planning Case Study Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan On the vanguard of thought. Reimagining The futurecancer of healthcare Care requires nothing less. Planning

More information

Vaccine Development in the Developing World; past, present and future: SEAR Perspective

Vaccine Development in the Developing World; past, present and future: SEAR Perspective Speech by Dr Samlee Plianbangchang Regional Director, WHO South-East Asia Vaccine Development in the Developing World; past, present and future: SEAR Perspective 15 June 2010 Bangkok, Thailand Vaccine

More information

Strategic Plan Executive Summary Society for Research on Nicotine and Tobacco

Strategic Plan Executive Summary Society for Research on Nicotine and Tobacco Strategic Plan 2013 2017 Executive Summary Society for Research on Nicotine and Tobacco Prepared By: Corona Insights Corona Insights, 2012 CoronaInsights.com CONTENTS Introduction... 1 Background... 1

More information

Peer Work Leadership Statement of Intent

Peer Work Leadership Statement of Intent Peer Work Leadership Statement of Intent A National Professional Association for Mental Health Peer Workers Peer work leaders from Queensland, Victoria and NSW and colleagues from the USA participated

More information

The Pharmacy Quality Alliance Optimizing Health by Advancing the Quality of Medication Use

The Pharmacy Quality Alliance Optimizing Health by Advancing the Quality of Medication Use Optimizing Health by Improving the Quality of Medication Use Adult Immunization Measure Development Update The Optimizing Health by Advancing the Quality of Medication Use Lisa Hines, PharmD Senior Director,

More information

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS 8-9 December 2015 Executive summary On 8-9 December,

More information

Draft First Report of The WHO Independent High-Level Commission on Non- Communicable Diseases

Draft First Report of The WHO Independent High-Level Commission on Non- Communicable Diseases New Delhi 16 th May 2018 Submission from AMARDEEP India, New Delhi WHO Web-based consultation 10-16 May 2018 regarding Draft First Report of The WHO Independent High-Level Commission on Non- Communicable

More information

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU July December 2012 Research Symposium on Digestive and Liver Diseases Brussels, 18 September 2012 Dr Myrto Azina- Chronides Ministry of Health Cyprus Digestive

More information

Innovation, Access and Delivery for Universal Health Coverage

Innovation, Access and Delivery for Universal Health Coverage A side event at the UHC Forum Co-hosted by UNDP and the GHIT Fund Tokyo, Japan 12 December 2017 Innovation, Access and Delivery for Universal Health Coverage From Innovation & Inequality, a UNDP-supported

More information

Program Officer, Sub-Saharan Africa: Population & Reproductive Health

Program Officer, Sub-Saharan Africa: Population & Reproductive Health Program Officer, Sub-Saharan Africa: Population & Reproductive Health Location: Los Altos, California Search conducted by: waldronhr.com The Organization The David and Lucile Packard Foundation is a family

More information

The Global AIESEC Leadership Initiative. Leadership for a Better World

The Global AIESEC Leadership Initiative. Leadership for a Better World The Global AIESEC Leadership Initiative 00 Leadership for a Better World 1" The Global AIESEC Leadership Initiative AIESEC youth and AIESEC alumni develop and activate leaders for a better world. Developing

More information

The road towards universal access

The road towards universal access The road towards universal access JAN 2006 Issues Paper Requests... that the UNAIDS Secretariat and its Cosponsors assist in facilitating inclusive, country-driven processes, including consultations with

More information

GOALS, OBJECTIVES, & STRATEGIES

GOALS, OBJECTIVES, & STRATEGIES GOALS, OBJECTIVES, & STRATEGIES HIGH PERFORMING ORGANIZATION Goal 1 Enhance the Bureau for Public Health s ability to function as an effective, efficient and flexible organization. a. Leadership skills

More information

DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN

DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN DRUG AND ALCOHOL TREATMENT ACTIVITY WORK PLAN 2016-2019 1 Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-2019 Primary Health Tasmania t: 1300 653 169 e: info@primaryhealthtas.com.au

More information

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap Background to development of vaccine roadmaps, to include priority areas for research, product development, capacities, and policy and commercialization Roadmaps as a Vehicle for Addressing Large- Scale

More information

2.2 The primary roles and responsibilities of the Committee are to:

2.2 The primary roles and responsibilities of the Committee are to: Edinburgh Child Protection Constitution 1. Introduction 1.1 This document sets out the governance arrangements established to promote the delivery of integrated, high quality child protection services

More information

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership Invitation to Comment This new draft strategy has been developed to ensure that the Forum continues to thrive, that we meet the needs of the community over the next five years, and that by acting together

More information

Contribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone

Contribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone COMMUNICATIONS AND AWARENESS MANAGER OVARIAN CANCER AUSTRALIA Contribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone National role Location: Melbourne CBD Position

More information

Update: Working Group on New Vaccines. David Lewinsohn Chair, Working Group on New Vaccines

Update: Working Group on New Vaccines. David Lewinsohn Chair, Working Group on New Vaccines Update: Working Group on New Vaccines David Lewinsohn Chair, Working Group on New Vaccines The Stop TB Partnership Global Partners' Forum Global TB Drug Facility GLC Coordinating Board Partnership Secretariat

More information

Implications for public health research. Professor Bernie Hannigan Director - Research, Translation & Innovation

Implications for public health research. Professor Bernie Hannigan Director - Research, Translation & Innovation Implications for public health research Professor Bernie Hannigan Director - Research, Translation & Innovation Our mission To protect and improve the nation s health and to address inequalities...working

More information

Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR)

Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR) Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR) Purpose How can we promote more investment into public research? How can we promote improved uptake

More information

DECLARATION OF THE 4 TH WORLD CONGRESS OF RURAL WOMEN HELD AT THE INTERNATIONAL CONVENTION CENTER, DURBAN, SOUTH AFRICA: APRIL 2007

DECLARATION OF THE 4 TH WORLD CONGRESS OF RURAL WOMEN HELD AT THE INTERNATIONAL CONVENTION CENTER, DURBAN, SOUTH AFRICA: APRIL 2007 DECLARATION OF THE 4 TH WORLD CONGRESS OF RURAL WOMEN HELD AT THE INTERNATIONAL CONVENTION CENTER, DURBAN, SOUTH AFRICA: 23 26 APRIL 2007 We, the Rural Women participating at the 4 th World Congress of

More information

State Innovations: Oral Health Integration in Statewide Delivery System and Payment Reform

State Innovations: Oral Health Integration in Statewide Delivery System and Payment Reform State Innovations: Oral Health Integration in Statewide Delivery System and Payment Reform Made possible by the Washington Dental Service Foundation Wednesday, June 22, 2016 2:00-3:00 pm ET For Audio Dial:

More information

The Global AIESEC Leadership Initiative. Leadership for a Better World

The Global AIESEC Leadership Initiative. Leadership for a Better World The Global AIESEC Leadership Initiative 00 Leadership for a Better World 1 The Global AIESEC Leadership Initiative AIESEC youth and AIESEC alumni develop and activate leaders for a better world. Developing

More information

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan Planning Case Study Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan On the vanguard of thought. Reimagining The futurecancer of healthcare Care requires nothing less. Planning

More information

Theresa NeSmith Centers for Disease Control and Prevention Center for Global Health Division of Global HIV/AIDS International Laboratory Branch

Theresa NeSmith Centers for Disease Control and Prevention Center for Global Health Division of Global HIV/AIDS International Laboratory Branch Theresa NeSmith Centers for Disease Control and Prevention Center for Global Health Division of Global HIV/AIDS International Laboratory Branch PEPFAR Laboratory Program is a Critical Part of Health Systems

More information

Thank you for the opportunity to submit testimony on the Fiscal Year (FY) 2014 State

Thank you for the opportunity to submit testimony on the Fiscal Year (FY) 2014 State Drugs for Neglected Diseases initiative, North America Jennifer Katz, Policy Director March 2013 Testimony to the Subcommittee on State and Foreign Operations, Committee on Appropriations United States

More information

UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN

UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN 2016-2020 1 2 OUR VISION Excellence in research is at the core of our vision for UC-Health Research Institute (HRI) which brings together critical mass in biomedicine,

More information

FIRST MEETING OF THE TECHNICAL ADVISORY GROUP ON PUBLIC HEALTH ENTOMOLOGY PAN AMERICAN HEALTH ORGANIZATION

FIRST MEETING OF THE TECHNICAL ADVISORY GROUP ON PUBLIC HEALTH ENTOMOLOGY PAN AMERICAN HEALTH ORGANIZATION SUMMARY FIRST MEETING OF THE TECHNICAL ADVISORY GROUP ON PUBLIC HEALTH ENTOMOLOGY PAN AMERICAN HEALTH ORGANIZATION The first meeting of the Technical Advisory Group on Public Health Entomology (TAG PHE),

More information

Opportunities in Pain Research with the NIH HEAL Initiative

Opportunities in Pain Research with the NIH HEAL Initiative Opportunities in Pain Research with the NIH HEAL Initiative Clinton Wright, M.D. Director, Division of Clinical Research National Institute of Neurological Disorders and Stroke, NIH September 20, 2018

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I August 2011 Rationale for including pharmacovigilance in the proposal Pharmacovigilance is the science and activities

More information

Letter from the CEO. Dear Friends of IAVI,

Letter from the CEO. Dear Friends of IAVI, IAVI Annual Report 2017 Letter from the CEO Dear Friends of IAVI, We are pleased to present an overview of the progress IAVI and partners have made in 2017 toward our pursuit of the development of vaccines

More information

Vaccine Innovation and Adult Immunization Landscape

Vaccine Innovation and Adult Immunization Landscape Vaccine Innovation and Adult Immunization Landscape National Adult and Influenza Immunization Summit, May 12-14, 2015 Phyllis Arthur Senior Director Vaccines, Immunotherapeutics & Diagnostics Policy parthur@bio.org

More information

Draft resolution submitted by the President of the General Assembly

Draft resolution submitted by the President of the General Assembly United Nations General Assembly Distr.: Limited 3 October 2018 Original: English Seventy-third session Agenda item 129 Global health and foreign policy Draft resolution submitted by the President of the

More information

Draft resolution submitted by the President of the General Assembly

Draft resolution submitted by the President of the General Assembly United Nations A/68/L.53 General Assembly Distr.: Limited 7 July 2014 Original: English Sixty-eighth session Agenda item 118 Follow-up to the outcome of the Millennium Summit Draft resolution submitted

More information

VACCINE MARKETS OVERVIEW SESSION

VACCINE MARKETS OVERVIEW SESSION VACCINE MARKETS OVERVIEW SESSION Robyn Iqbal Program Officer, Vaccine Delivery Market Dynamics UNICEF SD Manufacturers Meeting Copenhagen October 8, 2014 DRAFT Bill & Melinda Gates Foundation DISCUSSION

More information

Photo courtesy Conrad N. Hilton Foundation. EVALUATION OF THE Conrad N. Hilton Foundation Chronic Homelessness Initiative 2015 REPORT

Photo courtesy Conrad N. Hilton Foundation. EVALUATION OF THE Conrad N. Hilton Foundation Chronic Homelessness Initiative 2015 REPORT Photo courtesy Conrad N. Hilton Foundation. EVALUATION OF THE Conrad N. Hilton Foundation Chronic Homelessness Initiative 2015 REPORT December 2015 Executive Summary Under a September 2011 contract with

More information

Oklahoma Voluntary Organizations Active in Disaster (OKVOAD)

Oklahoma Voluntary Organizations Active in Disaster (OKVOAD) Oklahoma Voluntary Organizations Active in Disaster (OKVOAD) What is VOAD? National Voluntary Organizations Active in Disaster (VOAD) was founded almost 50 years ago in response to the challenges many

More information

Please accept, Excellency, the assurances of our highest consideration.

Please accept, Excellency, the assurances of our highest consideration. 20 July 2018 Excellency, We are honored to write to you in our capacity as co-facilitators to lead the intergovernmental consultations and negotiations on the modalities and outcomes of the High-Level

More information

Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment

Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment Rachael Eckles, JD/MA Director, Regulatory Policy Bristol-Myers Squibb August 10,

More information

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER SCIENTIFIC ADVISORY BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER Researchers from A*STAR s SBIC have discovered how changes in BCAA metabolism influence the development

More information

Environmental, Health and Safety

Environmental, Health and Safety Environmental, Health and Safety Codes of Practice The Environmental, Health and Safety (EHS) Codes of Practice set forth Zimmer EHS requirements for our business functions and facilities worldwide. In

More information

Ending HIV/AIDS in Southwest Minnesota

Ending HIV/AIDS in Southwest Minnesota Ending HIV/AIDS in Southwest Minnesota SUMMARY OF REGIONAL STAKEHOLDER INPUT July 2018 Prepared by Wilder Research ENDING HIV/AIDS IN SOUTHWEST MINNESOT A Ending HIV/AIDS in Southwest Minnesota Minnesota

More information

HealthHIV Core Capabilities

HealthHIV Core Capabilities Stakeholder and Community Engagement Supporting the Leadership of State, Territorial and Local Jurisdictions in Integrated HIV Prevention and Care Planning: Capacity Building and Technical Assistance Resources

More information

APTA EDUCATION STRATEGIC PLAN ( ) BOD Preamble

APTA EDUCATION STRATEGIC PLAN ( ) BOD Preamble APTA EDUCATION STRATEGIC PLAN (2006-2020) BOD 03-06-26-67 Preamble The content of the Education Strategic Plan represents the specific initiatives the American Physical Therapy Association (Association)

More information

REPORT. Global Forum for Health Research 8 Mexico City, 18 November 2004 (18:00-19:30) Special Interest Group: Oral Health

REPORT. Global Forum for Health Research 8 Mexico City, 18 November 2004 (18:00-19:30) Special Interest Group: Oral Health 2 December 2004 REPORT Global Forum for Health Research 8 Mexico City, 18 November 2004 (18:00-19:30) Special Interest Group: Oral Health The title of the meeting was "Towards an Oral Health Research Agenda",

More information

Poster Session HRT11420 Innovation Awards November 2014 Melbourne

Poster Session HRT11420 Innovation Awards November 2014 Melbourne Poster Session HRT11420 Innovation Awards November 2014 Melbourne When You Don t Know Where To Turn... Presenter: Claire Crocker, Director Delegates: Cathie Agg, Manager Patient Advocate Institute Anna

More information

Terms of Reference. Technical Specialist, Reproductive, Maternal, Child and Adolescent Health (RMNCAH) Official Job Title: Grade (Classified) P-4

Terms of Reference. Technical Specialist, Reproductive, Maternal, Child and Adolescent Health (RMNCAH) Official Job Title: Grade (Classified) P-4 Terms of Reference Official Job Title: Technical Specialist, Reproductive, Maternal, Child and Adolescent Health (RMNCAH) Duty Station: Nairobi, Kenya Grade (Classified) P-4 Duration Up to 3 years Background

More information

Australian Type 1 Diabetes. Research Resource Map

Australian Type 1 Diabetes. Research Resource Map Australian Type 1 Diabetes Research Resource Map 1 Introduction The Resource Mapping Project has been supported by the Macquarie Group Foundation through its pioneering, long term partnership with the

More information

Personalized medecine Biomarker

Personalized medecine Biomarker Patient Disease Diagnosis Risk prediction Personalized medecine Biomarker Targeted therapies Diagnostic Theranostic: Efficay Toxicity Treatment 1 THE CASE FOR PERSONALIZED MEDICINE IS COMPELLING.. Toxicity

More information

Epilepsy Foundation of Mississippi Strategic Plan

Epilepsy Foundation of Mississippi Strategic Plan Epilepsy Foundation of Mississippi Strategic Plan 2014-2017 Mission The Epilepsy Foundation of Mississippi leads the fight to stop seizures and SUDEP, find a cure, and overcome the challenges created by

More information

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people

More information

CORPORATE PROFILE 2018

CORPORATE PROFILE 2018 www.pskenya.org CORPORATE PROFILE 2018 OVERVIEW Population Services Kenya (PS Kenya) has been measurably improving the health of Kenyans since 1990. We address the most serious health challenges affecting

More information

Monitoring of the achievement of the health-related Millennium Development Goals

Monitoring of the achievement of the health-related Millennium Development Goals SIXTY-THIRD WORLD HEALTH ASSEMBLY WHA63.15 Agenda item 11.4 21 May 2010 Monitoring of the achievement of the health-related Millennium Development Goals The Sixty-third World Health Assembly, Having considered

More information

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I.

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I. COUNCIL OF THE EUROPEAN UNION Brussels, 24 May 2005 9278/05 DEVGEN 92 RELEX 257 SAN 74 ONU 61 ACP 73 NOTE from : General Secretariat dated 24 May 2005 No. prev. doc. : 9085/05 DEVGEN 88 RELEX 238 SAN 62

More information